Government Funded Inventions

We have several pages related specifically to the U.S. Bayh-Dole Act here.

KEI efforts to address pricing and other public interest issues in more than 30 different NIH licensing cases, involving both patents and data rights, are here: http://keionline.org/nih-licenses

KEI lawsuit against the NIH related to the license of CD30 CAR T patents to Gilead: https://www.keionline.org/kei-v-nih

Our work on the Sanofi/Army Zika vaccine license is here. https://keionline.org/zika-army

Our work on licensing cases from other U.S. Government agencies is here: https://www.keionline.org/other-USG-licenses

KEI efforts related to the failures to disclose Bayh-Dole rights: https://www.keionline.org/bayh-dole/failure-to-disclose

Xtandi is an Army and NIH funded invention, patented by UCLA. Our work on the efforts to get the Army or the NIH to use their march-in or royalty free license rights to obtain lower prices are collected here: https://keionline.org/xtandi

The work on government funded CRISPR inventions is here: http://keionline.org/crispr

The Fabrazyme patent disputes are here: https://keionline.org/fabry

The 2004 and 2012 ritonavir cases are here: https://keionline.org/ritonavir

Many of the other disputes and commentary on government funded inventions are listed below.